Micronised progesterone versus dydrogesterone: A randomised controlled trial

Progestogen for threatened miscarriage: A randomised controlled trial comparing micronised progester

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005251

Enrollment

Unknown

Registered

2014-09-21

Start date

2014-01-13

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Threatened Miscarriage

Interventions

Micronised progesterone:Micronised progesterone

Dydrogesterone:Dydrogesterone

Eligibility

Age

21 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Single intrauterine fetus (confirmed by ultrasonography) 2.Women presenting with pregnancy-related per vagina bleeding 3.Gestation weeks 6 to 10 (confirmed by ultrasonography)

Exclusion criteria

Exclusion criteria: 1.Treated with progesterone for previous per vagina bleeding in this current pregnancy; 2.Treated with progesterone for any other medical reasons in this current pregnancy; 3.Women diagnosed with inevitable miscarriage; 4.Women planning to terminate the pregnancy; 5.Women who are known to have recurrent miscarriages (3 or more consecutive pregnancy loss before 24 weeks of gestation); 6.Women who have pre-existing luteal phase deficiency or other forms of diagnosed progesterone deficiency.

Design outcomes

Primary

Measure	Time frame
Serum progesterone;Serum PIBF;Miscarriage;Bleeding pattern;Side effects;	—

Countries

China

Contacts

Public ContactTan Thiam Chye

tan.thiam.chye@kkh.com.sg+65 81211679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026